Loading clinical trials...
Loading clinical trials...
A Prospective Phase II Study of Adjuvant Cisplatin-Based Chemotherapy Followed by Maintenance Avelumab in Upper Tract Urothelial Carcinoma
Conditions
Interventions
Avelumab 10 mg/kg
Screening
+2 more
Locations
1
South Korea
Samsung Medical Center
Seoul, Gangnam, South Korea
Start Date
September 16, 2025
Primary Completion Date
July 1, 2026
Completion Date
July 2, 2029
Last Updated
November 6, 2025
NCT06668493
NCT07126119
NCT02547350
Lead Sponsor
Samsung Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions